Today: 22 January 2026
Subscribe
Browse Category

Stock Market News 12 December 2025

Chipotle Stock (CMG) Rallies on 4,000th Restaurant Milestone: Today’s News, Analyst Forecasts, and the 2026 Outlook (Dec. 12, 2025)

Chipotle Stock (CMG) Rallies on 4,000th Restaurant Milestone: Today’s News, Analyst Forecasts, and the 2026 Outlook (Dec. 12, 2025)

Chipotle Mexican Grill, Inc. (NYSE: CMG ) is back in the spotlight on Friday, December 12, 2025 , with shares rising after the company marked a major growth milestone: its 4,000th restaurant . As of the latest trade update, CMG was around $36.13 , up roughly $1.26 (about 3.6%) on the session, with an intraday range of $34.92 to $36.34…
12 December 2025
····
American Express Stock (NYSE: AXP) Today: News, Forecasts, and Analyst Outlook — Dec. 12, 2025

American Express Stock (NYSE: AXP) Today: News, Forecasts, and Analyst Outlook — Dec. 12, 2025

NEW YORK — Friday, December 12, 2025. American Express Company stock (NYSE: AXP) is in focus after a strong run that pushed shares to fresh 12‑month highs earlier this week—followed by a modest pullback in Friday trading. As of the latest available trade on Dec. 12, AXP was around $380.96, down roughly 1% on the day after opening near $386.49,…
12 December 2025
···
Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025)

Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025)

Merck & Co., Inc. (NYSE: MRK) stock traded higher on Friday, December 12, 2025, as investors weighed a new European regulatory tailwind for pulmonary arterial hypertension drug WINREVAIR (sotatercept) against a backdrop of policy-driven vaccine headlines, Keytruda-related legal friction in Europe, and a steady stream of Wall Street price-target updates. As of 17:07 UTC (midday New York trading), MRK shares…
12 December 2025
···
Pan American Silver Corp Stock (PAAS) News, Forecasts & Analysis — What’s Driving the Rally on December 12, 2025

Pan American Silver Corp Stock (PAAS) News, Forecasts & Analysis — What’s Driving the Rally on December 12, 2025

Updated for Friday, December 12, 2025. Ticker: NYSE: PAAS / TSX: PAAS. Pan American Silver Corp (PAAS) is back at the center of the precious-metals trade as silver prices push into record territory and investors reposition around a shifting rates backdrop. The move isn’t just macro-driven: Pan American has also delivered a busy stretch of company-specific catalysts in recent weeks—ranging…
12 December 2025
···
PepsiCo Stock (NASDAQ: PEP) News Today: Elliott Deal, Price Cuts, and the 2026 Forecast Wall Street Is Watching (Dec. 12, 2025)

PepsiCo Stock (NASDAQ: PEP) News Today: Elliott Deal, Price Cuts, and the 2026 Forecast Wall Street Is Watching (Dec. 12, 2025)

PepsiCo, Inc. (NASDAQ: PEP) is back in the spotlight on Friday, December 12, 2025, as investors digest a fast-moving mix of headlines: an Elliott-backed operating reset, a plan to cut roughly 20% of U.S. SKUs, and a newly detailed preliminary 2026 outlook that puts growth acceleration and margin expansion front and center. PepsiCo PEP traded around $149.55 on Friday, up…
12 December 2025
···
Cleveland-Cliffs Stock (NYSE: CLF) Slides After S&P Downgrade: Latest News, Forecasts, and Analyst Views for December 12, 2025

Cleveland-Cliffs Stock (NYSE: CLF) Slides After S&P Downgrade: Latest News, Forecasts, and Analyst Views for December 12, 2025

Cleveland-Cliffs (CLF) shares fell on Dec. 12, 2025 after S&P cut its credit rating to B+. Here’s what the downgrade means, what Wall Street forecasts suggest, and the key catalysts investors are watching into 2026. Cleveland-Cliffs Inc. (NYSE: CLF) is back in the spotlight on Friday, December 12, 2025 , after a credit-rating downgrade helped push the steelmaker’s shares lower—even…
12 December 2025
····
Wealthfront IPO: WLTH Debuts on Nasdaq After $485M Raise, Rings Opening Bell, and Tests Consumer Fintech Appetite

Wealthfront IPO: WLTH Debuts on Nasdaq After $485M Raise, Rings Opening Bell, and Tests Consumer Fintech Appetite

NEW YORK, Dec. 12, 2025 — Wealthfront, one of the best-known robo-advisers in US consumer finance, is officially entering the public markets today. The Palo Alto-based company priced its initial public offering at $14 per share , raising roughly $485–$486 million and setting up a Nasdaq debut under the ticker WLTH . GlobeNewswire The listing-day milestone comes with a high-profile…
12 December 2025
···
US Stock Market Today (Dec. 12, 2025): S&P 500 and Nasdaq Slide on Broadcom, Oracle as Investors Brace for Delayed Jobs & CPI Data

US Stock Market Today (Dec. 12, 2025): S&P 500 and Nasdaq Slide on Broadcom, Oracle as Investors Brace for Delayed Jobs & CPI Data

Updated: 12:30 p.m. ET (Friday, Dec. 12, 2025) U.S. stocks are pulling back at midday after a record-setting week for major benchmarks, with technology and AI-linked names leading the decline as investors reassess the pace—and profitability—of Big Tech’s massive AI buildout. Around 12:30 p.m. ET, trading action shows a clear split: the Nasdaq-heavy trade is under pressure, while the Dow’s more value-oriented mix has held…
12 December 2025
····
Top Stock Market Losers Today (Dec. 12, 2025): Broadcom, SanDisk, Oracle Slide as the AI Trade Cools at Midday

Top Stock Market Losers Today (Dec. 12, 2025): Broadcom, SanDisk, Oracle Slide as the AI Trade Cools at Midday

As of about 12:30 p.m. ET on Dec. 12, 2025, U.S. markets are pulling back—led by AI-linked tech. Broadcom is tumbling on margin concerns, Oracle is still digesting a capex shock, and several hardware and “AI-adjacent” names are among the day’s biggest losers. NEW YORK — Friday, Dec. 12, 2025 (12:30 p.m. ET update): The U.S. stock market’s late-year rally hit…
12 December 2025
····
Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune, Inc. (NASDAQ: ALT) is back on many biotech watchlists as investors weigh two competing forces: a near-term clinical and regulatory catalyst calendar for pemvidutide (the company’s lead asset) and a capital-raising backdrop that can quickly change the stock’s risk/reward profile. On Friday, Dec. 12, 2025 , ALT shares are trading in a volatility-heavy tape where options flow, analyst targets,…
12 December 2025
····
Big Tech Stocks Today Dec. 12, 2025: Broadcom and Oracle Rekindle AI Bubble Jitters as Mega Caps Slide

Big Tech Stocks Today Dec. 12, 2025: Broadcom and Oracle Rekindle AI Bubble Jitters as Mega Caps Slide

As of about 12:30 p.m. ET on Friday, Dec. 12, 2025, big tech stocks are under pressure as Broadcom’s margin warning and Oracle’s OpenAI data-center delays reignite “AI bubble” debate, while Nvidia’s China chip demand story and fresh Apple/Google legal headlines shape sentiment. NEW YORK — Big tech is having a rough midday on the U.S. stock market, with investors rotating away from AI-linked hardware and mega-cap growth after a…
12 December 2025
···
Wealthfront IPO Prices at $14, Raises $485 Million as WLTH Debuts on Nasdaq and Rings the Opening Bell

Wealthfront IPO Prices at $14, Raises $485 Million as WLTH Debuts on Nasdaq and Rings the Opening Bell

NEW YORK — Dec. 12, 2025 — Wealthfront, the digital wealth management platform best known for automated investing and high-yield cash products, has officially entered the public markets. The company priced its initial public offering at $14.00 per share, selling 34,615,384 shares—a deal size of about $485 million—and began its first day of trading on the Nasdaq Global Select Market…
12 December 2025
···
1 … 925 926 927 928 929 … 1,539

Stock Market Today

  • SLB Shares Show Strong Momentum Amid 46% Discount to Intrinsic Value
    January 22, 2026, 6:18 AM EST. SLB (NYSE:SLB) surged recently, posting a 26.58% gain in one month and 34.74% over three months, attracting investor attention. Despite a 7.01% decline over three years, the stock offers a compelling valuation based on its price-to-earnings (P/E) ratio of 19.9x, below the US energy services sector average of 22.2x. The firm recorded revenue of $35.247 billion and net income of $3.645 billion. Simply Wall St's discounted cash flow (DCF) model estimates SLB's intrinsic value at $90.62, implying shares trade at a 46% discount. The gap suggests the market may be factoring in risks or lower growth expectations. Investors should weigh recent momentum against these valuation metrics and risks in the energy services sector.
Go toTop